Australia’s PBS cemented in the healthcare system

Speculation about the US Administration’s views on the Pharmaceutical Benefits Scheme (PBS) has reconfirmed the sanctity of the PBS as the cornerstone of Australia’s healthcare system, the domestic pharma trade group stressed.

In responding to announcements from the US on tariffs, Liz de Somer, chief executive of Medicines Australia, said: “Speculation about the PBS has quite rightly prompted Australians to reaffirm their commitment to our PBS. Australia’s medicines industry, all sides of politics, patients, and clinicians all support patient access to new and breakthrough medicines through the PBS and want a stronger PBS now and in the future.”

“Strengthening the PBS though implementation of the health technology assessment (HTA) reform recommendations sitting on the Health Minister’s desk will ensure Australians see faster access to safe and effective, innovative medicines.